Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis

Table 2 Characteristics of selected newly diagnosed early RA patients

Subject	Antibody status (RF/ACPA)	DAS28 0 m	DAS28 6 m	Medication after baseline sampling
1	+/+	3.89	3.88	Mtx + GC
2	+/+	4.68	2.58^{B, D}	Mtx + GC
3	+/+	5.04	1.05^{B, D}	Mtx + GC
4	+/+	5.70	3.44^C	Mtx
5	+/+	7.39	2.24/2.53^{B, E}	Mtx + GC
6	+/+	5.47	3.46^C	Mtx
7	−/+	4.90	2.84^{A, B}	Mtx
8	−/−	5.52	2.39^{B, D}	Mtx + GC
9	+/+	5.49	1.63^{B, D}	Mtx + GC
10	+/+	4.31	2.63^{A. B}	Mtx

Abbreviations: DAS28 disease activity score 28, Mtx methotrexate, GC glucocorticoids
^A low disease activity; ^B remission; ^C moderate improvement; ^D good improvement; ^E DAS28 at 6 m not available, displayed are DAS28 at 3 m/13 m

ISSN: 1471-2172